10.1: General considerations The guidelines in this section apply to reports of possible transfusion-transmitted infection (TTI) arising from blood or blood components suppl…
9.5: Recommended standards for the reduction of bacterial contamination of blood components In recent years bacterial contamination of blood has been significantly reduced by the introdu…
9.1: General requirements All screening must be performed within Blood Safety and Quality Regulations1 (BSQR) compliant laboratories and meet any other appropriate regulatory …
9.6: Recommended standards for microbiological screening 9.6.1: Tissues All microbiological culture testing is subject to quality control tests in accordance with national acc…
Position paper on UK plasma - UK Forum 2022.pdf (605KB)
Consent for HCPs_checklist_v1_10.22.pdf (263KB)
CN 52-2022 - Infectious Diseases, Contact with.pdf (239KB)
CN 51-2022 - Coronavirus Infection (COVID-19).pdf (216KB)
Advancing Transfusion Going Paperless flyer.pdf (368KB)
Transfusing Wisely Webinar poster.pdf (252KB)
Minutes of the JPAC meeting 14-07-2022.pdf (368KB)
Confirmed RTT Minutes 31 March 2022.pdf (414KB)
Confirmed RTT Minutes 20 January 2022.pdf (143KB)
Confirmed RTT Minutes 5 July 2022.pdf (418KB)
Care of the Jehovah's Witness Patient.pdf (2MB)
08 June 2022.pdf (270KB)
RCHT_Vaginal Cell Salvage Case Reports.pdf (1MB)
Obstetric Haemorrhage.pdf (3MB)
Maternal Anaemia Management.pdf (2MB)
Clinically Significant Antibodies in Pregnancy.pdf (1MB)